[go: up one dir, main page]

FR2876586B1 - Composition pour prevenir ou traiter le stress, notamment les bouffees de stress chronique et permanent - Google Patents

Composition pour prevenir ou traiter le stress, notamment les bouffees de stress chronique et permanent

Info

Publication number
FR2876586B1
FR2876586B1 FR0411155A FR0411155A FR2876586B1 FR 2876586 B1 FR2876586 B1 FR 2876586B1 FR 0411155 A FR0411155 A FR 0411155A FR 0411155 A FR0411155 A FR 0411155A FR 2876586 B1 FR2876586 B1 FR 2876586B1
Authority
FR
France
Prior art keywords
stress
burns
preventing
composition
including chronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0411155A
Other languages
English (en)
Other versions
FR2876586A1 (fr
Inventor
Serge Sonie
Denis Marin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Persee Medica SAS
Original Assignee
Persee Medica SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Persee Medica SAS filed Critical Persee Medica SAS
Priority to FR0411155A priority Critical patent/FR2876586B1/fr
Priority to PCT/FR2005/002463 priority patent/WO2006042928A1/fr
Publication of FR2876586A1 publication Critical patent/FR2876586A1/fr
Application granted granted Critical
Publication of FR2876586B1 publication Critical patent/FR2876586B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0411155A 2004-10-20 2004-10-20 Composition pour prevenir ou traiter le stress, notamment les bouffees de stress chronique et permanent Expired - Fee Related FR2876586B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0411155A FR2876586B1 (fr) 2004-10-20 2004-10-20 Composition pour prevenir ou traiter le stress, notamment les bouffees de stress chronique et permanent
PCT/FR2005/002463 WO2006042928A1 (fr) 2004-10-20 2005-10-06 Composition pour prevenir ou traiter le stress, notamment les bouffees de stress chronique et permanent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0411155A FR2876586B1 (fr) 2004-10-20 2004-10-20 Composition pour prevenir ou traiter le stress, notamment les bouffees de stress chronique et permanent

Publications (2)

Publication Number Publication Date
FR2876586A1 FR2876586A1 (fr) 2006-04-21
FR2876586B1 true FR2876586B1 (fr) 2007-10-12

Family

ID=34950913

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0411155A Expired - Fee Related FR2876586B1 (fr) 2004-10-20 2004-10-20 Composition pour prevenir ou traiter le stress, notamment les bouffees de stress chronique et permanent

Country Status (2)

Country Link
FR (1) FR2876586B1 (fr)
WO (1) WO2006042928A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449486B2 (en) 2004-10-19 2008-11-11 Array Biopharma Inc. Mitotic kinesin inhibitors and methods of use thereof
ES2561330T3 (es) * 2007-10-17 2016-02-25 Rudolf Wild Gmbh & Co. Kg Composición que comprende extractos de toronjil
EP2881104A1 (fr) * 2013-12-05 2015-06-10 Lonza Ltd Utilisation de compositions comprenant de la phosphatidylsérine, de l'acide phosphatidique et/ou de ses sels pour réduire ou prévenir la transpiration
US20180000881A1 (en) * 2015-01-22 2018-01-04 Bob Fritz Phosphatidylserine-Containing Diet Supplement Aids With Melatonin Anti-Catabolic Dietary Nutrients
FR3159746A1 (fr) 2024-03-01 2025-09-05 Patyka Cosmetics Utilisation cosmétique de Melissa officinalis pour diminuer les manifestations associées au stress

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617542A1 (de) * 1967-04-26 1971-04-08 Isnel Afife Dipl Chem Dr Verfahren zum Herstellen von stabilen Loesungen von Lecithin,besonders Soyabohnenlecithin,in waessrigem,zuckerhaltigen Alkohol
ATE213593T1 (de) * 1995-03-31 2002-03-15 Schuer Joerg Peter Prof Verfahren zur haltbarkeitsverbesserung und/oder stabilisierung von mikrobiell verderblichen produkten
AU2548899A (en) * 1998-02-23 1999-09-06 Taiyo Kagaku Co. Ltd. Composition comprising theanine
WO2002047701A1 (fr) * 2000-12-12 2002-06-20 Angiolab, Inc. Composition comprenant un extrait de feuilles de melisse presentant une activite d'inhibition sur l'angiogenese et sur des metalloproteases matricielles
US6753017B2 (en) * 2001-11-07 2004-06-22 Jrs Pharma Lp Process for preparing dry extracts

Also Published As

Publication number Publication date
FR2876586A1 (fr) 2006-04-21
WO2006042928A1 (fr) 2006-04-27

Similar Documents

Publication Publication Date Title
DK1615952T3 (da) Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
EP1796666A4 (fr) Methodes et compositions de traitement de l'hyperlipidemie
EP2192901A4 (fr) Agents chimiques, compositions et procédés de traitement et de prévention des infections à orthopoxvirus et des maladies associées
SI1771201T1 (sl) Sestavki in metode za zdravljenje ali preprečevanje z oksalatom-povezanih bolezni
BRPI0716354A2 (pt) "composiÇço e mÉtodo"
CL2007003155A1 (es) Compuestos derivados de 3,7-diazabiciclo[3.3.0]octano o 3,7-diazabiciclo[3.3.1]nonano, moduladores de receptores nicotinicos neuronales; composicion farmaceutica; y uso en el tratamiento de trastornos del snc.
IL182837A0 (en) Methods, assays and compositions for treating retinol-related diseases
CA2645871A1 (fr) Compositions pharmaceutiques et methodes destinees a traiterou prevenir une maladie associee a l'oxalate
BRPI0309513A2 (pt) composição para tratamento de fibras com efeito durável
WO2006091459A3 (fr) Compositions et methodes permettant de traiter la permeabilite vasculaire
PL1651042T3 (pl) Kompozycja chwastobójcza o zwiększonym działaniu chwastobójczym i sposób zwiększania działania chwastobójczego
EP1806120A4 (fr) Composition pour prevenir ou diminuer la pigmentation
DE602005013968D1 (de) Polyorganosiloxan und härtbare zusammensetzung daraus
FR2908042B1 (fr) Ensemble d'intubation monocanaliculonasal et/ou monocanaliculaire,notamment pour l'imperforation lacrymonasale.
FI20040119L (fi) Kahvikoostumus ja menetelmä sen valmistamiseksi
EP1812054A4 (fr) Procédés et compositions d'immunisation contre l'infection par pseudomonas
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
WO2009033183A3 (fr) Composés et procédés de traitement du virus de l'hépatite c et conditions associées à la liaison cd81
FR2904558B1 (fr) "composition de facteur vii recombinant ou transgenique, presentant majoritairement des formes glycanniques biantennees, bisialylees et non fucosylees"
EP2019586A4 (fr) Médicaments destinés à traiter les douleurs aiguës, fondés sur des associations diclofénac-opioïde à action rapide
FR2876586B1 (fr) Composition pour prevenir ou traiter le stress, notamment les bouffees de stress chronique et permanent
NO20053348D0 (no) Farmasoytisk sammensetning for behandling av virusangrep.
EP1838292A4 (fr) Preparation destinee a prevenir ou traiter les deficiences en calcium chez les mammiferes
BRPI0614481A2 (pt) composto, composição farmecêutica, uso do composto, e, método de tratamento de distúrbios mediados por mglur5
WO2005094391A3 (fr) COMPOSITIONS ET METHODES DE TRAITEMENT ET DE PREVENTION D'UNE MALADIE ASSOCIEE A L'INTEGRINE αVβ5

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100630